Jin Y, Li S, Li S. Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia". Haematologica; https://doi.org/10.3324/haematol.2026.301606 [Early view].